Clinical Trial Update: Lentiviral Gene Therapy for X-Linked Chronic Granulomatous Disease (X-CGD) [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 trial of lentiviral gene therapy for X-linked chronic granulomatous disease has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Granulomatous Disease

Drugs mentioned

• Lentiviral gene therapy for X-linked chronic granulomatous disease

Snippet

Sponsor: Great Ormond Street Hospital for Children NHS Foundation Trust | Conditions: Granulomatous Disease, Chronic, X-linked, Variant | Phase 1, Phase 2 | Status: WITHDRAWN